Clever Leaves (CLVR) Competitors $0.0001 0.00 (-50.00%) (As of 12/24/2024 02:37 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends CLVR vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Clever Leaves vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity 180 Life Sciences (NASDAQ:ATNFW) and Clever Leaves (NASDAQ:CLVR) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations. Do insiders & institutionals have more ownership in ATNFW or CLVR? 6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor ATNFW or CLVR? In the previous week, 180 Life Sciences had 1 more articles in the media than Clever Leaves. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Clever Leaves. 180 Life Sciences' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Clever Leaves Neutral Is ATNFW or CLVR more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Clever Leaves N/A N/A N/A Which has better valuation and earnings, ATNFW or CLVR? 180 Life Sciences has higher earnings, but lower revenue than Clever Leaves. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AClever Leaves$17.42M0.00-$17.90M-$11.310.00 Does the MarketBeat Community believe in ATNFW or CLVR? Clever Leaves received 13 more outperform votes than 180 Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AClever LeavesOutperform Votes1381.25% Underperform Votes318.75% SummaryClever Leaves beats 180 Life Sciences on 4 of the 5 factors compared between the two stocks. Ad DarwinHow Low-Cost Stocks Generate Monthly IncomeAre you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 Get Clever Leaves News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLVR vs. The Competition Export to ExcelMetricClever LeavesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$6.71B$5.22B$9.25BDividend YieldN/A3.00%5.12%4.29%P/E Ratio0.0010.6387.5917.28Price / Sales0.00195.821,166.50119.73Price / CashN/A57.1543.2337.83Price / Book0.005.164.834.93Net Income-$17.90M$151.58M$120.46M$225.34M7 Day PerformanceN/A4.12%2.85%4.14%1 Month PerformanceN/A-3.99%19.70%1.16%1 Year PerformanceN/A10.33%30.57%16.98% Clever Leaves Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLVRClever LeavesN/A$0.00-50.0%N/A-100.0%$0.00$17.42M0.00560Gap DownATNFW180 Life SciencesN/A$0.01+6.7%N/A+85.2%$0.00N/A0.007Gap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.04-6.8%N/A+42.2%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.05-2.7%N/A-82.3%$0.00$40,633.000.0040Positive NewsALVOWAlvotechN/A$2.95+5.0%N/A+33.8%$0.00$391.87M0.004ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.10+106.3%N/AN/A$0.00N/A0.004High Trading VolumeBFRIWBiofronteraN/A$0.12+33.3%N/A+500.0%$0.00$35.36M0.0070BTMDWbioteN/A$0.47-2.2%N/A-53.5%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.23-18.5%N/A-81.4%$0.00N/A0.008Gap UpCELUWCelularityN/A$0.02-5.0%N/A-25.1%$0.00$48.20M0.00220 Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ACABW Alternatives BFRIW Alternatives BTMDW Alternatives BCTXW Alternatives CELUW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLVR) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clever Leaves With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
